VentureMed Group
PrivateLast Round
Series C
Oct 29, 2025
Total Funding Raised
$51M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
VentureMed Group is a medical device company that develops and markets endovascular medical devices for the treatment of peripheral arterial disease and stenoses of arteriovenous fistulas and grafts.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VentureMed Group Comparables
Compare VentureMed Group with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cardio Flow, Inc. | 82% | |
| Stryker Corporation | 81% | |
| Neomend | 79% | |
VentureMed Group Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Oct 29, 2025 | ||||
| Convertible Debt | Feb 12, 2025 | ||||
| Convertible Debt | Jan 31, 2023 | ||||
| Convertible Debt | Nov 23, 2021 | ||||
| Series B | Aug 15, 2017 | ||||
Series A | Dec 1, 2014 |
Key People
Founding team and executive leadership
VentureMed Group Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RiverVest Venture Partners | Convertible Debt, Series B |
| Endeavour Vision | Convertible Debt, Series C, Series B |
| S3 Ventures | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2026
Bruce Fiedler appointed as Chief Financial Officer.
- Oct 29, 2025
$28M round completed.
VentureMed Group Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about VentureMed Group's valuation, stock price, and market status.